SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-00-046045
Filing Date
2000-10-26
Accepted
2000-10-26 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND L PBIOTECHNOLOGY VALUE FUND.II, L.P.BVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G a2028583zsc13g.txt SC 13G 19463
  Complete submission text file 0000912057-00-046045.txt   21950
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44055 | Film No.: 746504
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice